The UCT Clinical Trials Unit, housed within the Desmond Tutu HIV Centre (DTHC) at the University of Cape Town, is committed to the pursuit of excellence in research, treatment, training and prevention of HIV and related infections in Southern Africa
In 2013 the Desmond Tutu HIV Foundation partnered with the Faculty of Health Sciences, Departments of Medicine and Pharmacology at the University of Cape Town to establish an expanded Clinical Trials Unit.
Our CTU model regards training and development as an important function. We invest in our staff through a robust and agile training program that positively impacts performance of our study teams.
Home > Home


Wednesday, 23 September 2020
FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic

The U.S. Food and Drug Administration today approved Descovy (emtricitabine 200 mg and tenofovir alafenamide 25 mg) in at-risk adults and adolescents weighing at least 35kg for HIV-1 pre-exposure prophylaxis (PrEP) to reduce the risk of HIV-1 infection from sex, excluding those who have receptive vaginal sex. Descovy is not indicated in individuals at risk of HIV-1 infection from receptive vaginal sex because the effectivness in this population has not been evaluated.

Publication Date:
Fri, 11 Oct 2019 - 21:30
ADM Giroir
ADM Giroir Discusses Ending the HIV Epidemic: A Plan for America with APHA

ADM Brett Giroir, MD, Assistant Secretary for Health, recently spoke to the American Public Health Association (APHA) about Ending the HIV Epidemic: 

Publication Date:
Fri, 11 Oct 2019 - 21:00
Dr. Linda-Gail Bekker President of the International Aids Society, Q and A

Dr. Linda-Gail Bekker began a two-year term as president of the International AIDS Society.

Publication Date:
Thu, 16 Aug 2018 - 09:30
The Amsterdam Affirmation

Much has changed since the global HIV community convened at the previous International AIDS Conference in Durban in 2016. 

Publication Date:
Tue, 14 Aug 2018 - 15:45